Stella (Xinyan) Sun is an associate in the Capital Markets practice. Stella advises companies on their public disclosures, SEC and NYSE/Nasdaq compliance matters and corporate governance matters. Representative companies include Bunge Limited, CVS Health Corporation, Glatfelter Corporation and Quest Diagnostics Incorporated.
She also represents public and private companies and underwriters in a wide variety of debt and equity capital markets transactions, including high yield and investment grade debt offerings, initial public offerings, liability management and acquisition financings.
Expertise
Experience
Representative matters
The underwriters on the IPO and NYSE listing of Paragon 28, Inc.
CVS Health on its $1 billion bond offering and related $2.05 billion cash tender offer for its outstanding senior notes.
The underwriters on a $4.75 billion senior notes offering by Lowe's Companies, Inc.
Glatfelter Corporation on its offering of $500 million senior notes offering.
The joint book-running managers on the $609.5 million initial public offering of Elliott Opportunity II, a special-purpose acquisition company.
Itaú Corpbanca on its approximately $1 billion rights offering.
Qualifications
Admissions
New York
Academic
Nankai University Bachelor of Economics
New York University School of Law J.D.
Languages
Mandarin
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.